Details of the Drug

General Information of Drug (ID: DMJ38X9)

• Drug Name: PEG-bHb-CO
• Synonyms: Sanguinate; Oxygen transfer agent (trauma/cardiovascular disease), Prolong Pharmaceuticals; PEG-bHb-CO (trauma/cardiovascular disease); PEGylated bovine hemoglobin-carbon monoxide (trauma/cardiovascular disease), Prolong Pharmaceuticals; PEG-bHb-CO (trauma/cardiovascular disease), Prolong Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Phase 2/3	[1]
Cerebral ischemia	8B11	Phase 2	[2]
Sickle-cell disorder	3A51	Phase 2	[3]

• Cross-matching ID: TTD ID: D0A6LT
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT02490202) Efficacy and Safety of SANGUINATE for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)